$OPHT IVERIC bio, Inc. Insider Trading Week 44/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IVERIC bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IVERIC bio, Inc. in week 44/2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 06 2015 | OPHT | Ophthotech Corp. | PATEL SAMIR CHANDRAKANT | President | Sell | S | 54.80 | 3,665 | 200,842 | 278,605 | 282.3 K to 278.6 K (-1.30 %) |
| Nov 06 2015 | OPHT | Ophthotech Corp. | PATEL SAMIR CHANDRAKANT | President | Sell | S | 53.95 | 4,200 | 226,590 | 282,270 | 286.5 K to 282.3 K (-1.47 %) |
| Nov 06 2015 | OPHT | Ophthotech Corp. | PATEL SAMIR CHANDRAKANT | President | Sell | S | 53.06 | 12,822 | 680,335 | 286,470 | 299.3 K to 286.5 K (-4.28 %) |
| Nov 06 2015 | OPHT | Ophthotech Corp. | PATEL SAMIR CHANDRAKANT | President | Buy | M | 0.00 | 40,000 | 0 | 299,292 | 259.3 K to 299.3 K (+15.43 %) |
| Nov 04 2015 | OPHT | Ophthotech Corp. | GALAKATOS NICHOLAS | Director | Sell | S | 54.00 | 500 | 27,000 | 7,445 | 7.9 K to 7.4 K (-6.29 %) |
| Nov 04 2015 | OPHT | Ophthotech Corp. | GALAKATOS NICHOLAS | Director | Sell | S | 54.00 | 1,000 | 54,000 | 13,184 | 14.2 K to 13.2 K (-7.05 %) |
| Nov 03 2015 | OPHT | Ophthotech Corp. | GUYER DAVID R | Chief Executive Off ... | Option Exercise | M | 10.03 | 18,582 | 186,377 | 224,666 | |
| Nov 03 2015 | OPHT | Ophthotech Corp. | GUYER DAVID R | Chief Executive Off ... | Sell | S | 50.27 | 100 | 5,027 | 29,910 | 30 K to 29.9 K (-0.33 %) |
| Nov 03 2015 | OPHT | Ophthotech Corp. | GUYER DAVID R | Chief Executive Off ... | Sell | S | 49.88 | 18,482 | 921,882 | 30,010 | 48.5 K to 30 K (-38.11 %) |
| Nov 03 2015 | OPHT | Ophthotech Corp. | GUYER DAVID R | Chief Executive Off ... | Buy | M | 10.03 | 18,582 | 186,377 | 48,492 | 29.9 K to 48.5 K (+62.13 %) |